Troy A. Ignelzi

Troy A. Ignelzi has an estimated net worth of $24.3 Million. This is based on reported shares across multiple companies, which include Karuna Therapeutics, Inc., Esperion Therapeutics, Inc., , scPharmaceuticals Inc., Contineum Therapeutics, Inc., Rapport Therapeutics, Inc., and Harmony Biosciences Holdings, Inc..

2021 was Troy A. Ignelzi's most active year for acquiring shares with 16 total transactions. Troy A. Ignelzi's most active month to acquire stocks was the month of January. 2020 was Troy A. Ignelzi's most active year for disposing of shares, totalling 28 transactions. Troy A. Ignelzi's most active month to dispose stocks was the month of August. 2022 saw Troy A. Ignelzi paying a total of $465,621.20 for 99,111 shares, this is the most they've acquired in one year. In 2022 Troy A. Ignelzi cashed out on 104,355 shares for a total of $11,653,532.91, their largest year based on trade value.